<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Piramal Pharma Limited

NSE: PPLPHARMA · Lot size: 2625

OverviewOption ChainOI AnalysisFII / DIIMax Pain

Piramal Pharma Limited FII & DII Activity

FII Net (₹ Cr)
-1,059.93
Buy 12,756.88 · Sell 13,816.81
DII Net (₹ Cr)
+2,966.89
Buy 18,753.06 · Sell 15,786.17
FII F&O Net (contracts)
+0
Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-04-21-1,059.93+2,966.89
2026-04-20+683.2-4,721.48
2026-04-18+683.2-4,721.48
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

Foreign Institutional Investors (FIIs) sold ₹1059.93 Cr in cash today, reflecting continued risk-off positioning amid global volatility. Domestic Institutional Investors (DIIs) countered with strong inflows of ₹2966.89 Cr, signaling robust local confidence. This divergence underscores a tug-of-war between foreign profit-booking and domestic accumulation.

Trend vs 5-Day Average

Today's FII outflow marks a reversal from their 5-day average inflow of ₹683.2 Cr, indicating a sharp shift in sentiment. In contrast, DII buying is a trend break, reversing their recent 5-day average outflow of ₹4721.48 Cr, showcasing renewed domestic appetite.

F&O Positioning Signal

FII F&O cash stood at ₹0 Cr, suggesting no immediate directional hedging or speculative positioning. However, the FII Index Futures Long/Short ratio at 1.2 indicates underlying bullish conviction in broader markets despite equity outflows.

Implication for Finance

Strong DII inflows and constructive F&O positioning may support financials and pharma stocks like Piramal Pharma Limited tomorrow, even amid foreign selling pressure.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21

Related Analysis

Same Sector

ABB
ABB India Limited
Neutral
ABCAPITAL
Aditya Birla Capital Limited
Neutral
ADANIENSOL
Adani Energy Solutions Limited
Neutral
ADANIENT
Adani Enterprises Limited
Neutral
ADANIGREEN
Adani Green Energy Limited
Neutral

Frequently Asked Questions

What is FII net buying/selling in Piramal Pharma Limited today?▾
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹1,059.93 Cr (net selling) as of 2026-04-21. This market-wide figure applies to all F&O stocks including Piramal Pharma Limited.
What is DII activity in Piramal Pharma Limited today?▾
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹2,966.89 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Piramal Pharma Limited today?▾
FII net F&O position (index + stock futures combined) is +0 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Piramal Pharma Limited?▾
Block deal data for Piramal Pharma Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Piramal Pharma Limited stock price?▾
FII and DII flows are market-wide data — all F&O stocks including Piramal Pharma Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Piramal Pharma Limited's individual OI buildup type, this provides a directional framework.